We show that high CD34 expression is associated with poor therapy response as measured by MRD at EOI and that clinical cases of CD34‐positive ALL express genes associated with stemness, migration, adhesion, and survival. This evidence concerns the gene CD34 and acute lymphoblastic leukemia.